BioLife Solutions (BLFS) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Why Goldman Sachs expects Fed to skip October rate hike
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
SICP, OMID, ELME, More
Revenue Growth %: +3.9%
Financial Fact:
Research and development: 496.87K
Today's EPS Names:
SICP, OMID, ELME, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.01 million.
BioLife Solutions reaffirmed FY2016 guidance.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ponce Financial Group, Inc. (PDLB) Tops Q3 EPS by 24c
- Alliance Resource Partners (ARLP) Tops Q3 EPS by 23c
- StoneX Reiterates Buy Rating on Popular, Inc. (BPOP)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
